Evidence map›Paper›PMID 18434400›Full record

ArticleJournal of virology2008

HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.

Christine M Rousseau, Marcus G Daniels, Jonathan M Carlson, Carl Kadie, Hayley Crawford, Andrew Prendergast, Philippa Matthews, Rebecca Payne, Morgane Rolland, Dana N Raugi and 13 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 141 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

Christine M RousseauDepartment of Microbiology, University of Washington, 1959 NE Pacific Street, Box 358070, Seattle, WA 98195-8070, USA. cmr@u.washington.edu
Marcus G Daniels
Jonathan M Carlson
Carl Kadie
Hayley Crawford
Andrew Prendergast
Philippa Matthews
Rebecca Payne
Morgane Rolland
Dana N Raugi
Brandon S Maust
Gerald H Learn
David C Nickle
Hoosen Coovadia
Thumbi Ndung'u
Nicole Frahm
Christian Brander
Bruce D Walker
Philip J R Goulder
Tanmoy Bhattacharya
David E Heckerman
Bette T Korber
James I Mullins
University of Washington · USHarvard University · USMicrosoft (United States) · USSanta Fe Institute · USUniversity of KwaZulu-Natal · ZAHoward Hughes Medical Institute · USLos Alamos National Laboratory · USMassachusetts General Hospital · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Neutralizing Antibody Induction by Centralized GenesP01AI061734 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F. · 2005 to 2009
$11.7M
Occurrence and Outcome of Dual HIV-1 InfectionR37AI047734 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2005 to 2014
$5.9M
OCCURRENCE AND OUTCOME OF DUAL HIV-1 INFECTIONR01AI047734 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2000 to 2004
$2.4M
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopesR01AI067077 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAUFMANN, DANIEL E · 2005 to 2009
$1.9M
HIV-1 and Host Cell Changes in Disease ProgressionR01AI058894 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 2004 to 2007
$1.9M
Medical Research Council G0500384NIAID NIH HHS AI047734NIAID NIH HHS AI058894NIAID NIH HHS AI061734NIAID NIH HHS AI067077NIAID NIH HHS AI11514NIAID NIH HHS AI27005NIAID NIH HHS AI27757NIAID NIH HHS N01-AI-15422NIAID NIH HHS P01 AI061734NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI047734NIAID NIH HHS R01 AI058894NIAID NIH HHS R01 AI067077NIAID NIH HHS R37 AI047734
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) mutations that confer escape from cytotoxic T-lymphocyte (CTL) recognition can sometimes result in lower viral fitness. These mutations can then revert upon transmission to a new host in the absence of CTL-mediated immune selection pressure restricted by the HLA alleles of the prior host. To identify these potentially critical recognition points on the virus, we assessed HLA-driven viral evolution using three phylogenetic correction methods across full HIV-1 subtype C proteomes from a cohort of 261 South Africans and identified amino acids conferring either susceptibility or resistance to CTLs. A total of 558 CTL-susceptible and -resistant HLA-amino acid associations were identified and organized into 310 immunological sets (groups of individual associations related to a single HLA/epitope combination). Mutations away from seven susceptible residues, including four in Gag, were associated with lower plasma viral-RNA loads (q < 0.2 [where q is the expected false-discovery rate]) in individuals with the corresponding HLA alleles. The ratio of susceptible to resistant residues among those without the corresponding HLA alleles varied in the order Vpr > Gag > Rev > Pol > Nef > Vif > Tat > Env > Vpu (Fisher's exact test; P < or = 0.0009 for each comparison), suggesting the same ranking of fitness costs by genes associated with CTL escape. Significantly more HLA-B (chi(2); P = 3.59 x 10(-5)) and HLA-C (chi(2); P = 4.71 x 10(-6)) alleles were associated with amino acid changes than HLA-A, highlighting their importance in driving viral evolution. In conclusion, specific HIV-1 residues (enriched in Vpr, Gag, and Rev) and HLA alleles (particularly B and C) confer susceptibility to the CTL response and are likely to be important in the development of vaccines targeted to decrease the viral load.

Indexed as

Evolution, MolecularPhylogenyAmino Acid SequenceBase SequenceEpitopes, T-LymphocyteGenes, MHC Class IHIV-1HIV InfectionsHumansImmunity, CellularMolecular Sequence DataSequence Analysis, DNASouth AfricaT-Lymphocytes, CytotoxicViremiaEpitopes, T-Lymphocyte

Identifiers

PMID18434400
PMCPMC2447109
OpenAlexW2118836866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.